Time Spent In Target Glucose Range in Women With T2D Diabetes in Pregnancy

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

June 1, 2026

Conditions
Diabete Type 2Pregnancy in Diabetic
Interventions
DEVICE

Dexcom Continuous Glucose Monitoring

A continuous glucose monitor (CGM) is a wearable device that tracks blood glucose (sugar) every few minutes, throughout the day and night. The readings are relayed in real time to a device which can be read by the patient, caregiver or health-care provider, even remotely

Trial Locations (1)

Unknown

RECRUITING

Mount Sinai Hospital, Toronto

All Listed Sponsors
collaborator

University of Manitoba

OTHER

collaborator

Women's College Hospital

OTHER

lead

Mount Sinai Hospital, Canada

OTHER